CLINICAL_TRIALS
trial_result
· 2012-02-02
Clinical Trial Update: Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions [Phase 3]
Summary
A Phase 3 trial evaluating direct stenting with the TAXUS Liberté SR drug-eluting stent for de novo coronary artery lesions has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED